RXSIGHT, INC. (RXST)
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
Dynatrace to Acquire Bindplane to Establish Telemetry Pipelines for AI and Cloud‑Native Observability
Utz Brands, Inc. to Report First Quarter 2026 Financial Results on May 6, 2026
Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
Oracle Responds to TRC Capital Mini-Tender Offer
OptimizeRx Appoints Mary Varghese Presti to Board of Directors
MFS Investment Grade Municipal Trust Announces Optional Partial Redemption of Preferred Shares
Ethan Allen Announces Release Date for its Fiscal 2026 Third Quarter Results
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Infleqtion Announces 2026 Revenue Guidance of $40 Million